Arthur M. Krieg - Jun 16, 2021 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc. (CMPI)

Role
Chief Scientific Officer
Signature
/s/ Katherine Eade, attorney-in-fact
Stock symbol
CMPI
Transactions as of
Jun 16, 2021
Transactions value $
$22,112
Form type
4
Date filed
6/17/2021, 04:33 PM
Previous filing
Jun 1, 2021
Next filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMPI Common Stock Purchase $22.1K +3.58K +0.44% $6.18 809K Jun 16, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions, at prices ranging from $6.17 to $6.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Remarks:

Exhibit 24 - Power of Attorney